Kelly E. Caudle, PharmD, PhD, BCPS
Clinical Pharmacogenetics Implementation Consortium (CPIC) Principal Investigator and Director
Dr. Caudle oversees all CPIC-related projects and the CPIC guideline development process including the coordination of the guideline writing committees, the guideline evidence reviews, and the writing of the guideline manuscript and supplement. Furthermore, Dr. Caudle is involved in the clinical implementation of pharmacogenetics at St. Jude Children's Research Hospital. Dr. Caudle received her PharmD and PhD from the University of Tennessee Health Science Center and completed an ASHP-accredited PGY2 residency at Le Bonheur Children’s Hospital. She is also a board‐certified Pharmacotherapy Specialist. Dr. Caudle is currently an affiliate Assistant Professor at the University of Tennessee Health Science Center.
The Increased Complexity of Pharmacogenomic Associations: What to Do about Contributions by Multiple Drug-Metabolizing Genes and Pharmacodynamic Genes
9:00–9:30 AM (CDT)
Friday, September 23, 2022